Global Opioid-Induced Constipation Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

SKU ID : GIR- 12970643

Publishing Date : 15-Jan-2019

No. of pages : 137

PRICE
3480
6960

  • Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation.

    Scope of the Report:
    This report focuses on the Opioid-Induced Constipation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
    The opioid analgesics produce analgesia by the activation of the mu receptors found in the CNS and PNS. These drugs affect the motility, tone, and contractility of the bowel functions, which results in the delay in the transit of fecal contents. The opioids also cause a reduction in the secretion of digestive enzymes and also cause partial gastroparesis. Some of the common symptoms of opioid-induced constipation are hard and dry stools, painful defecation, bloating, distention and bulged abdomen, feeling lethargic, and loss of appetite.
    The worldwide market for Opioid-Induced Constipation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.

    Market Segment by Manufacturers, this report covers
    AstraZeneca
    Takeda Pharmaceutical
    Valeant Pharmaceuticals International
    Abbott
    Bayer
    Boehringer Ingelheim
    C.B. Fleet
    Cosmo Pharmaceuticals
    Daewoong
    Daiichi Sankyo
    GlaxoSmithKline
    Ironwood Pharmaceuticals
    Johnson & Johnson
    Merck
    Mundipharma
    Nektar Therapeutics
    Pfizer
    Progenics Pharmaceuticals
    Shionogi
    SLA Pharma
    Sucampo
    Synergy Pharmaceuticals
    Theravance

    Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    Solid
    Liquid

    Market Segment by Applications, can be divided into
    Drugstore
    Hospital
    Others

    There are 15 Chapters to deeply display the global Opioid-Induced Constipation market.
    Chapter 1, to describe Opioid-Induced Constipation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
    Chapter 2, to analyze the top manufacturers of Opioid-Induced Constipation, with sales, revenue, and price of Opioid-Induced Constipation, in 2016 and 2017;
    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
    Chapter 4, to show the global market by regions, with sales, revenue and market share of Opioid-Induced Constipation, for each region, from 2013 to 2018;
    Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
    Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
    Chapter 12, Opioid-Induced Constipation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
    Chapter 13, 14 and 15, to describe Opioid-Induced Constipation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports